News DongKook Pharmaceutical Co., Ltd.

Equities

A086450

KR7086450004

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
18,640 ^KRW	-2.56%		+4.90%	+15.35%

05-16	DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-14	DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12/04/22	MT
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17/03/22	CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
YJM Games Co., Ltd. announced that it has received KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd.	17/08/21	CI
YJM Games Co., Ltd. announced that it expects to receive KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd., and other investors	10/08/21	CI
Hanchang Corporation announced that it has received KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation	27/12/20	CI
Hanchang Corporation announced that it expects to receive KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation	22/12/20	CI
DongKook Pharmaceutical Co., Ltd. announced that it has received KRW 10.0000516 billion in funding	17/07/18	CI
DongKook Pharmaceutical Co., Ltd. announced that it expects to receive KRW 10.0000516 billion in funding	02/07/18	CI
GS Instruments Co. Ltd. announced that it has received KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.	02/05/16	CI
GS Instruments Co. Ltd. announced that it expects to receive KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.	05/04/16	CI
DONGKOOK Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 13, 2015 has expired.	12/09/15	CI
DONGKOOK Pharmaceutical Co., Ltd.(KOSDAQ:A086450) added to Russell Global Index	29/06/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News DongKook Pharmaceutical Co., Ltd.

Equities

A086450

KR7086450004

Summary

Filters